Literature DB >> 22227873

The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data.

W Robert Simons1, Lisa C Rosenblatt, Digisha N Trivedi.   

Abstract

OBJECTIVE: Determine the prevalence and costs of rheumatoid arthritis (RA) during three consecutive years: 2004, 2005, and 2006.
METHODS: Medical Expenditure Panel Survey was used for persons with RA. Regressions estimate health care costs and income loss. Absenteeism and age-adjusted workforce participation compared means and rates.
RESULTS: The prevalence of RA was 0.40% in 2004, 0.44% in 2005, and 0.43% in 2006. Health care cost associated with RA was $4422, $2902, and $1882 (all P < 0.01) in 2004, 2005, and 2006, respectively. Rheumatoid arthritis sufferers were employed, 36.8%, 39.5%, and 44% compared with 70.5%, 69.8%, and 71%. Individuals with RA also missed more days of work, 4.86 in 2004 (P = 0.04), 1.70 in 2005 (P = 0.22), and 2.99 in 2006 (P = 0.04). Rheumatoid arthritis reduced income by $2404 (P = 0.03), $2207 (P < 0.001), and $1212 (P = 0.002).
CONCLUSIONS: Costs of RA are considerable.

Entities:  

Mesh:

Year:  2012        PMID: 22227873     DOI: 10.1097/JOM.0b013e31823c13e7

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  6 in total

Review 1.  Racial and ethnic disparities in rheumatoid arthritis.

Authors:  Christine A McBurney; Ernest R Vina
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.

Authors:  Andrew Hresko; Tzu-Chieh Lin; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-10       Impact factor: 4.794

3.  Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.

Authors:  Theresa M Hunter; Natalie N Boytsov; Xiang Zhang; Krista Schroeder; Kaleb Michaud; Andre B Araujo
Journal:  Rheumatol Int       Date:  2017-04-28       Impact factor: 2.631

Review 4.  Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.

Authors:  Rafael Alfonso-Cristancho; Nigel Armstrong; Ramesh Arjunji; Rob Riemsma; Gill Worthy; Rita Ganguly; Jos Kleijnen
Journal:  Clin Rheumatol       Date:  2016-10-10       Impact factor: 2.980

Review 5.  A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with Appraisal of Guidelines for Research and Evaluation II.

Authors:  Lucie Brosseau; Prinon Rahman; Stéphane Poitras; Karine Toupin-April; Gail Paterson; Christine Smith; Judy King; Lynn Casimiro; Gino De Angelis; Laurianne Loew; Sabrina Cavallo; Jessica Mc Ewan
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 6.  Timing of rehabilitation on length of stay and cost in patients with hip or knee joint arthroplasty: A systematic review with meta-analysis.

Authors:  Michael Masaracchio; William J Hanney; Xinliang Liu; Morey Kolber; Kaitlin Kirker
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.